Portal hypertension of cirrhotic origin in terms of immediate and longterm results of transjugular intrahepatic portosystemic stent bypass surgery (TIPS) with selective embolization of gastric veins

Objective: to improve the results of surgical treatment of patients with liver cirrhosis complicated by cirrhotic portal hypertension using transjugular intrahepatic portosystemic stent bypass surgery (TIPS) with selective gastric vein embolization.

Materials and methods: 62 patients with liver cirrhosis complicated by portal hypertension were examined and treated surgically. Group 1 included 27 patients admitted for surgical treatment using TIPS with selective embolization of the left gastric vein, while group 2 included 35 patients who underwent TIPS with embolization of two or more gastric veins.

Materials and methods: clinical and laboratory examination, instrumental diagnostic methods, surgical and statistical methods.

Results: complications such as portosystemic shunt thrombosis were found in 11.11% of patients in group I versus 8.57% in group II, recurrent variceal bleeding episodes in group I occurred in 22.22% versus none in group II, and mortality in group I was 11.11% versus 5.71% in group II. The risk of recurrent variceal gastric bleeding in group II patients was zero, necessitating selective embolization of two or more gastric veins.

Conclusion: when performing TIPS surgery, embolization of two or more gastric veins is advisable, given the absence of a risk of variceal gastric bleeding in this patient population when shunt thrombosis occurs.

1. Kotiv B.N., Dzidzava I.I., Bugaev S.A., Onnitsev I.E., Soldatov S.A., et al. Minimally invasive ways to treat and prevent gastroesophageal portal bleeding. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2022;27(2):48--57. (In Russ.) https://doi.org/10.16931/1995-5464.2022-2-48-57

2. Sapronova N.G., Kantsurov R.N., Stagniev D.V., Frolova A.A. Results of a personalized approach to surgical correction of portal hypertension in patients with liver cirrhosis. Medical Herald of the South of Russia. 2024;15(2):54-60. (In Russ.) https://doi.org/10.21886/2219-8075-2024-15-2-54-60

3. Huang Y, Li J, Zheng T, Ji D, Wong YJ, et al. Development and validation of a machine learning-based model for varices screening in compensated cirrhosis (CHESS2001): an international multicenter study. Gastrointest Endosc. 2023;97(3):435-444.e2. Erratum in: Gastrointest Endosc. 2023;98(3):472. https://doi.org/10.1016/j.gie.2022.10.018

4. Manukyan G.V., Musin R.A., Lebezev V.M., Zhigalova S.B., Kitsenko E.A., et al. Refractory ascites of complex genesis in patients with a severe combined form of extrahepatic portal hypertension. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2022;27(1):87-93. (In Russ.) https://doi.org/10.16931/1995-5464.2022-1-87-93

5. Kozyrevskiy M.A., Khoronko YU.V., Blikyan A.V., Krivorotov N.A., Kolomiets K.V.Method for early diagnosis of hepatorenal syndrome in portal hypertension of cirrhotic origin. Colloquium-journal. 2021;12(99): 64-65. (In Russ.) eLIBRARY ID: 46447370 EDN: DUDBSB

6. de Franchis R; Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743-752. https://doi.org/10.1016/j.jhep.2015.05.022.